Literature DB >> 6267225

Characterization of benzodiazepine and gamma-aminobutyric recognition sites and their endogenous modulators.

M Massotti, A Guidotti, E Costa.   

Abstract

The solubilization and partial purification from rat brain cortex homogenates of [3H]gamma-aminobutyric acid (GABA) and [3H]diazepam recognition sites and of their endogenous modulators (GABA-modulin and an endogenous compound which specifically bound [3H]diazepam) are reported. A high percentage of GABA binding sites (virtually free of benzodiazepine binding sites) was solubilized from homogenates of rat brain cortex incubated at 0 degree C with 1% Triton X-100 and a mixture of protease inhibitors. A large proportion of benzodiazepine binding sites was solubilized in the absence of apparent GABA binding capacity by incubating crude synaptic membrane preparations at 37 degree C with 0.05% Triton X-100. The characteristics of these two solubilized binding sites resemble those of the membrane-bound binding sites. However, unlike the membrane-bound sites, solubilized GABA and benzodiazepine binding sites are insensitive to GABA stimulation, while solubilized GABA binding sites are no longer protected by the benzodiazepines against heat inactivation. These results indicate that GABA and benzodiazepine recognition sites reside in two different molecules which, when bound to membranes, can interact reciprocally and modulate their binding affinity for specific ligands.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267225      PMCID: PMC6564137     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  12 in total

1.  Cerebellar GABAA receptor binding and function in vitro in two rat lines developed for high and low alcohol sensitivity.

Authors:  M Uusi-Oukari; E R Korpi
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

2.  Purification and characterization of a benzodiazepine-like substance from mammalian brain.

Authors:  C C Liao; H S Lin; J Y Liu; L S Hibbard; J Y Wu
Journal:  Neurochem Res       Date:  1989-04       Impact factor: 3.996

3.  The stokes radius of the CHAPS-solubilized benzodiazepine receptor complex.

Authors:  J P Ray; S T Mernoff; L Sangameswaran; A L de Blas
Journal:  Neurochem Res       Date:  1985-09       Impact factor: 3.996

Review 4.  Biochemical dissection of the gamma-aminobutyrate synapse.

Authors:  A J Turner; S R Whittle
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

5.  Methods for removing endogenous factors from CNS membrane preparations: differences in [3H]GABA binding parameters and developmental-related effects.

Authors:  S Fiszer de Plazas; M C Gravielle; A Mitridate de Novara; V Flores
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

6.  Cortical benzodiazepine receptor binding in a rabbit model of hepatic encephalopathy: the effect of Triton X-100 on receptor solubilization.

Authors:  M Rössle; K D Mullen; E A Jones
Journal:  Metab Brain Dis       Date:  1989-09       Impact factor: 3.584

7.  Intrinsic GABAergic system of adrenal chromaffin cells.

Authors:  Y Kataoka; Y Gutman; A Guidotti; P Panula; J Wroblewski; D Cosenza-Murphy; J Y Wu; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Phosphorylation induces a decrease in the biological activity of the protein inhibitor (GABA-modulin) of gamma-aminobutyric acid binding sites.

Authors:  B C Wise; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

9.  Physical separation and characterization of two types of benzodiazepine receptors.

Authors:  M M Lo; S M Strittmatter; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Isolation, characterization, and purification to homogeneity of a rat brain protein (GABA-modulin).

Authors:  A Guidotti; D R Konkel; B Ebstein; M G Corda; B C Wise; H Krutzsch; J L Meek; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.